JP2001347153A - Method for preparing tablet - Google Patents

Method for preparing tablet

Info

Publication number
JP2001347153A
JP2001347153A JP2000174710A JP2000174710A JP2001347153A JP 2001347153 A JP2001347153 A JP 2001347153A JP 2000174710 A JP2000174710 A JP 2000174710A JP 2000174710 A JP2000174710 A JP 2000174710A JP 2001347153 A JP2001347153 A JP 2001347153A
Authority
JP
Japan
Prior art keywords
granules
cellulose
powder
tablet
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000174710A
Other languages
Japanese (ja)
Inventor
Etsuo Kamata
悦雄 鎌田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Original Assignee
Asahi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Corp filed Critical Asahi Kasei Corp
Priority to JP2000174710A priority Critical patent/JP2001347153A/en
Publication of JP2001347153A publication Critical patent/JP2001347153A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Glanulating (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method for preparing a tablet having small weight dispersion and excellent in moldability and collapsibility. SOLUTION: This method for preparing the tablet comprises wet-granulating powder containing 2-30 wt.% cellulose powder to prepare granulated powder having 60-300 &mu;m average particle size, <=3.0 particle size uniformity, 1.5-2.5 ml/g apparent specific volume and 35-42 deg. repose angle and then compressing the granulated powder by a wet compressing method.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、重量バラツキが小
さく、成形性及び崩壊性の良好な錠剤を製造する方法に
関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing a tablet having a small weight variation and good moldability and disintegration properties.

【0002】[0002]

【従来の技術】結晶セルロースは直接打錠法あるいは湿
式後末添加打錠法(顆粒を製造した後、さらに結晶セル
ロースを添加して打錠する方法)においては、成形性と
崩壊性の両機能を兼ね備えた賦形剤である。しかし、粉
体を湿式造粒する場合に、予め結晶セルロースを添加し
て造粒した場合には、成形性及び崩壊性機能が低下する
場合がある。
2. Description of the Related Art In a direct tableting method or a tableting method in which wet cellulose powder is added (a method in which granules are produced and then tableted with microcrystalline cellulose), both functions of moldability and disintegration are considered. An excipient that also has However, when the powder is wet-granulated and granulated by adding crystalline cellulose in advance, the moldability and disintegration function may be reduced.

【0003】米国特許第5866166号には、この現
象は造粒及び乾燥工程において、セルロース粒子の擬角
質化が起こるためではないかとして、その防止のため、
セルロース粒子にコロイダルシリカを少量混合した組成
物を使用することが提案されている。しかし、混合物の
場合、混合状態の不均一さにより性能が変わることが予
想され、また、配合禁忌の問題もあり好ましくない。
According to US Pat. No. 5,866,166, this phenomenon may be caused by pseudo-keratinization of cellulose particles in the granulation and drying steps.
It has been proposed to use a composition in which a small amount of colloidal silica is mixed with cellulose particles. However, in the case of a mixture, it is expected that the performance will change due to the unevenness of the mixing state, and there is also a problem of incompatibilities with the mixture, which is not preferable.

【0004】[0004]

【発明が解決しようとする課題】本発明は、セルロース
粉末を造粒時に添加した後、打錠する湿式打錠法におい
て、特定の顆粒物性を持つ顆粒を製造することによっ
て、重量バラツキが小さく、成形性、崩壊性の良好な錠
剤を製造する方法を提供するものである。
SUMMARY OF THE INVENTION The present invention provides a wet tableting method in which cellulose powder is added at the time of granulation, followed by tableting. By producing granules having specific granular properties, weight variation is small. It is intended to provide a method for producing a tablet having good moldability and disintegration properties.

【0005】[0005]

【課題を解決するための手段】本発明者は鋭意検討の結
果、セルロース粉末を配合した粉体を造粒し、顆粒物性
を特定の範囲にコントロールすることで、重量バラツキ
が小さく、成形性、崩壊性の良好な錠剤を製造できるこ
とを見出し、本発明を完成した。すなわち、本発明は、
下記の通りである。セルロース粉末を2〜30重量%含
有する粉体を湿式造粒し顆粒を製した後、打錠する湿式
打錠法により錠剤を製造する方法であって、顆粒が、平
均粒径60〜300μm、粒径均一度3.0以下、粗比
容積1.5〜2.5ml/g、安息角35〜42度であ
ることを特徴とする、錠剤の製造方法。
Means for Solving the Problems As a result of intensive studies, the present inventor has granulated a powder containing a cellulose powder, and controlled the physical properties of the granules to a specific range, so that the weight variation was small, the moldability was low, and The inventors have found that tablets having good disintegration properties can be produced, and have completed the present invention. That is, the present invention
It is as follows. A method for producing tablets by wet granulation of a powder containing 2 to 30% by weight of a cellulose powder to produce granules, followed by tableting, wherein the granules have an average particle size of 60 to 300 μm, A method for producing a tablet, characterized by having a particle size uniformity of 3.0 or less, a crude specific volume of 1.5 to 2.5 ml / g, and a repose angle of 35 to 42 degrees.

【0006】以下、本発明について詳細に説明する。本
発明で用いるセルロース粉末としては、結晶セルロー
ス、粉末セルロースなどであり、リンター、パルプなど
のセルロース質を酸加水分解及び/またはアルカリ酸化
分解により分解後、精製し、乾燥して得られるものであ
る。酸あるいはアルカリによる分解を行わずに機械的に
粉砕することにより得ることもできる。なかでも結晶セ
ルロースが好ましい。
Hereinafter, the present invention will be described in detail. The cellulose powder used in the present invention includes crystalline cellulose, powdered cellulose, and the like, and is obtained by decomposing cellulosic substances such as linters and pulp by acid hydrolysis and / or alkali oxidative decomposition, and then purifying and drying. . It can also be obtained by mechanical pulverization without decomposition with an acid or alkali. Among them, crystalline cellulose is preferred.

【0007】粉体中のセルロース粉末の配合量は、2〜
30重量%である。セルロース粉末の配合量が2重量%
未満の場合、得られた顆粒を打錠して得た錠剤の重量バ
ラツキがやや大きく、また、錠剤硬度が十分でない。ま
た、セルロース粉末の配合量が30重量%を超えると、
顆粒が緻密になりにくいため粗比容積が大きくなる。従
って、流動性が悪くなるため、錠剤重量のバラツキが大
きくなる。本発明に適するセルロース粉末の物性につい
て説明する。平均粒径は15〜200μmであることが
好ましい。15μm未満では充分な錠剤硬度が得られな
い傾向がある。また、200μmを超えると他の粉体と
の混合性が悪く、成分の分離が起こりやすい傾向にあ
る。より好ましくは30〜150μmである。さらに好
ましくは40〜120μmである。
[0007] The compounding amount of the cellulose powder in the powder is 2 to
30% by weight. 2% by weight of cellulose powder
If it is less than 1, the weight variation of the tablet obtained by tableting the obtained granules is slightly large, and the tablet hardness is not sufficient. Further, when the amount of the cellulose powder exceeds 30% by weight,
Since the granules are hard to be dense, the coarse specific volume increases. Accordingly, the fluidity is deteriorated, and the weight of the tablet varies widely. The physical properties of the cellulose powder suitable for the present invention will be described. The average particle size is preferably from 15 to 200 μm. If it is less than 15 μm, sufficient tablet hardness tends not to be obtained. On the other hand, if it exceeds 200 μm, the mixing property with other powders is poor, and the components tend to be easily separated. More preferably, it is 30 to 150 μm. More preferably, it is 40 to 120 μm.

【0008】また、粗比容積は2.0〜3.8ml/g
であることが好ましい。2.0ml/g未満では、錠剤
硬度が充分に出ない傾向にある。3.8ml/gを超え
ると、顆粒が緻密になりにくいため、顆粒の流動性が悪
くなり、錠剤重量のバラツキが大きくなる傾向にある。
特に好ましくは2.2〜3.4ml/gである。また、
重合度は100〜350であることが好ましい。100
未満では、錠剤硬度が不充分となる傾向にある。また、
錠剤の崩壊性が悪化する傾向にある。350を超える
と、顆粒が緻密になりにくいため、顆粒の流動性が悪く
なり、錠剤重量のバラツキが大きくなる傾向にある。特
に好ましくは120〜300である。
The crude specific volume is 2.0-3.8 ml / g.
It is preferred that If it is less than 2.0 ml / g, the tablet hardness tends to be insufficient. If it exceeds 3.8 ml / g, the granules are less likely to be dense, so that the fluidity of the granules deteriorates and the variation in tablet weight tends to increase.
Particularly preferably, it is 2.2 to 3.4 ml / g. Also,
The degree of polymerization is preferably from 100 to 350. 100
If it is less than 3, the tablet hardness tends to be insufficient. Also,
Tablet disintegration tends to deteriorate. If it exceeds 350, the granules are less likely to be dense, so that the fluidity of the granules deteriorates and the variation in tablet weight tends to increase. Particularly preferably, it is 120 to 300.

【0009】また、保水性は150〜300g/gが好
ましい。150未満では、錠剤硬度が充分に出ない傾向
にある。また、錠剤の崩壊性が悪くなる傾向にある。3
00を超えると、顆粒が緻密になりにくいため、顆粒の
流動性が悪くなり、錠剤重量のバラツキが大きくなる傾
向にある。特に好ましくは、180〜280である。顆
粒物性について説明する。顆粒の平均粒径は60〜30
0μmであることが必要である。60μm未満では、顆
粒の流動性が充分でなく、錠剤の重量バラツキが大とな
る。300μmを超えると、錠剤の崩壊性が悪化する。
好ましくは60〜250μmである。特に好ましくは8
0〜200μmである。顆粒の粒径均一度は3.0以下
であることが必要である。粒径均一度は以下の式で定義
されるものである。
The water retention is preferably from 150 to 300 g / g. If it is less than 150, the tablet hardness tends to be insufficient. In addition, the disintegration of tablets tends to be poor. Three
If it exceeds 00, the granules are hard to be dense, so that the fluidity of the granules is deteriorated and the variation in tablet weight tends to be large. Particularly preferably, it is 180 to 280. The physical properties of granules will be described. The average particle size of the granules is 60 to 30
It needs to be 0 μm. If it is less than 60 μm, the fluidity of the granules is not sufficient, and the weight variation of the tablets becomes large. If it exceeds 300 μm, the disintegration of the tablet will deteriorate.
Preferably it is 60 to 250 μm. Particularly preferably 8
0 to 200 μm. The particle size uniformity of the granules needs to be 3.0 or less. The particle size uniformity is defined by the following equation.

【0010】 粒径均一度=(d50/d10 + d90/d50)/2 ここで、d90は平均粒径の測定時に求まる、累積重量百
分率が90%の時の粒径であり、d10は積重量百分率が
10%の時の粒径である。粒径均一度が3.0を超える
と、粒度分布が広いため、顆粒の流動性が悪化する。好
ましくは2.8以下である。特に好ましくは2.5以下
である。顆粒の粗比容積は1.5〜2.5ml/gであ
る。1.5ml/g未満では、顆粒の塑性変形性が低下
するため、錠剤硬度が充分ではない。また、2.5ml
/gを超えると、打錠時の臼内への充填がスムーズに行
かないため、錠剤重量のバラツキが大きくなる。好まし
くは1.5〜2.2ml/gである。特に好ましくは
1.5〜2.0ml/gである。顆粒の安息角は35〜
42度である。35度未満では、顆粒にさらに賦形剤を
配合して打錠する場合、賦形剤と顆粒の分離が起きるた
め好ましくない。42度を超えると、錠剤の重量バラツ
キが大となる。これらの顆粒物性の制御は、結合液量及
びその添加速度、あるいは造粒条件(撹拌速度、撹拌時
間、槽内温度など)を変化させることにより行う。
Particle size uniformity = (d50 / d10 + d90 / d50) / 2 where d90 is a particle size obtained when the average particle size is measured and the cumulative weight percentage is 90%, and d10 is a product weight. This is the particle size when the percentage is 10%. If the particle size uniformity exceeds 3.0, the fluidity of the granules deteriorates because the particle size distribution is wide. Preferably it is 2.8 or less. Especially preferably, it is 2.5 or less. The coarse specific volume of the granules is between 1.5 and 2.5 ml / g. If the amount is less than 1.5 ml / g, the plastic deformability of the granules decreases, so that the tablet hardness is not sufficient. 2.5 ml
/ G, the filling of the mortar during tableting does not proceed smoothly, and the variation in tablet weight increases. Preferably it is 1.5-2.2 ml / g. Particularly preferably, it is 1.5 to 2.0 ml / g. Angle of repose of granules is 35 ~
42 degrees. If the temperature is less than 35 degrees, when excipients are further blended with the granules and tableting is performed, the excipients and the granules are separated, which is not preferable. If it exceeds 42 degrees, the weight variation of the tablets becomes large. The control of the physical properties of these granules is carried out by changing the amount of the binding solution and the rate of addition thereof, or the granulation conditions (stirring speed, stirring time, tank temperature, etc.).

【0011】セルロース粉末以外に配合する粉体として
は、薬効成分の他、以下のものがあげられる。賦形剤と
しては、乳糖、D−マンニトール、白糖、エリスリトー
ル、トレハロースなどの糖類、糖アルコール類、トウモ
ロコシデンプン、バレイショデンプン、部分アルファー
化デンプン等のデンプン類、リン酸水素カルシウム、タ
ルク、軽質無水ケイ酸、含水二酸化ケイ素などの無機物
質類、などがある。また、崩壊剤としては、カルメロー
スCa、低置換度ヒドロキシプロピルセルロース、クロ
スカルメロースNaなどのセルロース誘導体類、トウモ
ロコシデンプン、カルボキシメチルスターチNa、ヒド
ロキシプロピルスターチ、部分アルファー化デンプンな
どのデンプン及びデンプン誘導体類、クロスポビドンな
どの合成高分子類、などがある。
As the powder to be compounded in addition to the cellulose powder, the following may be mentioned in addition to the medicinal ingredient. Excipients include sugars such as lactose, D-mannitol, sucrose, erythritol, trehalose, sugar alcohols, starches such as corn starch, potato starch, partially pregelatinized starch, calcium hydrogen phosphate, talc, light anhydrous silica. Acids, inorganic substances such as hydrous silicon dioxide, and the like. Examples of disintegrants include carmellose Ca, low-substituted hydroxypropylcellulose, cellulose derivatives such as croscarmellose Na, corn starch, carboxymethyl starch Na, hydroxypropyl starch, starch and starch derivatives such as partially pregelatinized starch. And synthetic polymers such as crospovidone.

【0012】結合剤としては、ヒドロキシプロピルセル
ロース、ヒドロキシプロピルメチルセルロース、カルメ
ロースNa、メチルセルロース等のセルロース誘導体
類、デンプン糊などのデンプン類、ポビドンなどの合成
高分子類などがある。その他、着色料、着香料など医薬
品等の添加物として通常配合される成分を添加できる。
顆粒の製造法は、撹拌造粒法、高速撹拌造粒法、流動層
造粒法、転動型流動層造粒法、押出造粒法、破砕造粒法
など、通常粉体の造粒に使用される造粒法を用いること
ができるが、なかでも撹拌造粒法、高速撹拌造粒法、転
動型流動層造粒法が好ましい。特に好ましくは、高速撹
拌造粒法である。短時間で造粒が終了する点、顆粒の平
均粒径を小さく調整しても流動性が比較的良好な点で、
本発明に使用する造粒法として適している。
Examples of the binder include cellulose derivatives such as hydroxypropylcellulose, hydroxypropylmethylcellulose, carmellose Na and methylcellulose; starches such as starch paste; and synthetic polymers such as povidone. In addition, components that are usually blended as additives such as pharmaceuticals such as coloring agents and flavors can be added.
Granule production method is usually granulation of powder, such as stirring granulation method, high speed stirring granulation method, fluidized bed granulation method, tumbling fluidized bed granulation method, extrusion granulation method, crushing granulation method, etc. The granulation method used can be used, and among them, the stirring granulation method, the high-speed stirring granulation method, and the tumbling fluidized bed granulation method are preferable. Particularly preferred is a high-speed stirring granulation method. The point that granulation is completed in a short time, the point that the fluidity is relatively good even if the average particle size of the granules is adjusted small,
It is suitable as a granulation method used in the present invention.

【0013】造粒時の結合液としては、先に記載した結
合剤の水溶液を作成して、粉体に滴下、あるいは噴霧す
るなどして加えればよい。あるいは結合剤粉体を他の粉
体中に混合し、水のみを滴下、あるいは噴霧しても良
い。あるいは、粉体中のセルロース粉末には結合効果が
あるので、結合剤は添加せずに水のみを滴下、あるいは
噴霧してもかまわない。造粒後の湿顆粒は、造粒機から
取り出して、棚段で乾燥しても良いし、あるいは流動層
乾燥機に仕込んで、乾燥しても良い。
As the binding liquid at the time of granulation, an aqueous solution of the binder described above may be prepared and added to the powder by dripping or spraying. Alternatively, the binder powder may be mixed with another powder, and only water may be dropped or sprayed. Alternatively, since the cellulose powder in the powder has a binding effect, only water may be dropped or sprayed without adding a binder. The wet granules after granulation may be taken out of the granulator and dried in a tray, or may be charged in a fluidized bed dryer and dried.

【0014】得られた顆粒に、ステアリン酸マグネシウ
ム等の滑沢剤を添加し、通常の方法で打錠を行う。滑沢
剤を添加する前に、結晶セルロース、粉末セルロース等
のセルロース粉末、乳糖等の賦形剤あるいは崩壊剤等を
必要に応じて添加してもかまわない。
A lubricant such as magnesium stearate is added to the obtained granules, and tableting is carried out in a usual manner. Before adding the lubricant, a cellulose powder such as crystalline cellulose or powdered cellulose, an excipient such as lactose, or a disintegrant may be added as necessary.

【0015】[0015]

【発明の実施の形態】以下に、実施例によって本発明を
さらに詳細に説明する。なお、セルロース粉末、顆粒、
錠剤の物性評価方法は下記の通りである。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in more detail by way of examples. In addition, cellulose powder, granules,
The method for evaluating the physical properties of the tablet is as follows.

【0016】セルロース粉末の物性評価方法 ・平均粒径(μm) セルロース粉末30gを目開き500、300、15
0、106、75、45μmの篩を用いて、ロータップ
篩分機で15分間篩分し、また、セルロース粉末5gを
用いて、エアジェットシーブで篩分し、おのおのの篩の
篩上重量百分率(%)を求め、累積重量百分率が50%
の時の粒径(d50)で表す。 ・粗比容積(ml/g) パウダーテスターを用いて求める。 ・重合度 日本薬局方13改正の結晶セルロースあるいは粉末セル
ロースの項に記載される重合度測定法により求める。 ・保水性(g/g) セルロース粉末5gを50mlの蒸留水中に分散させた
後、遠心沈降機で2000Gをかけて10分間遠心処理
をする。続いて、上澄みを静かに除いた後、湿潤したセ
ルロース粉末の重量を測定し、含まれる水の重量を求
め、5で除した値を保水性とする。
Method for evaluating physical properties of cellulose powder ・ Average particle size (μm) 30 g of cellulose powder is opened with openings 500, 300, and 15
Using a sieve of 0, 106, 75, or 45 μm, the mixture is sieved for 15 minutes by a low tap sieving machine, and 5 g of cellulose powder is sieved by an air jet sieve. ) And the cumulative weight percentage is 50%
At the time of (d50).・ Rough specific volume (ml / g) Determined using a powder tester. -Degree of polymerization Determined by the method of measuring the degree of polymerization described in the section of crystalline cellulose or powdered cellulose in the Japanese Pharmacopoeia 13, revised. Water retention (g / g) After dispersing 5 g of cellulose powder in 50 ml of distilled water, the mixture is centrifuged at 2,000 G for 10 minutes using a centrifugal sedimenter. Subsequently, after the supernatant is gently removed, the weight of the wet cellulose powder is measured, the weight of the contained water is determined, and the value divided by 5 is defined as the water retention.

【0017】顆粒の物性評価方法 ・平均粒径(μm) 乾燥した顆粒を1410μmで篩った後、顆粒30gを
目開き1000、710、500、300、212、1
50、106、75μmの篩を用いて、ロータップ篩分
機で15分間篩分し、篩上重量百分率(%)を求め、累
積重量百分率が50%の時の粒径(d50)で表す。 ・粒径均一度 平均粒径の測定時に求まる、累積重量百分率が90%の
時の粒径(d90)と積重量百分率が10%の時の粒径
(d10)を用いて、以下の式により求める。 粒径均一度=(d50/d10 + d90/d50)/2 ・粗比容積(ml/g) 1410μmを通過する顆粒を用い、パウダーテスター
により測定し、5回の平均で表す。 ・安息角(度) 1410μmを通過する顆粒を用い、パウダーテスター
により測定し、5回の平均で表す。
Method for evaluating physical properties of granules: Average particle size (μm) After sieving the dried granules at 1410 μm, 30 g of the granules are opened to 1000, 710, 500, 300, 212, and 1,
Using a 50, 106, or 75 μm sieve, the mixture is sieved for 15 minutes using a low-tap sieving machine, and the weight percentage (%) on the sieve is determined, and is represented by the particle size (d50) when the cumulative weight percentage is 50%. Particle size uniformity Using the particle size when the cumulative weight percentage is 90% (d90) and the particle size when the cumulative weight percentage is 10% (d10), which is obtained when measuring the average particle size, is given by the following formula. Ask. Particle size uniformity = (d50 / d10 + d90 / d50) / 2 Coarse specific volume (ml / g) Using a granule passing through 1410 μm, measured by a powder tester and expressed as an average of five measurements. Angle of repose (degree) Measured with a powder tester using granules passing through 1410 μm, and expressed as an average of 5 measurements.

【0018】錠剤の物性評価方法 ・錠剤重量バラツキ(CV値) 錠剤10個の重量をそれぞれ秤り、以下の式により求め
る。
Method for evaluating physical properties of tablets: Tablet weight variation (CV value) The weight of 10 tablets is weighed and determined by the following formula.

【0019】CV値(%)=100×標準偏差(mg)
/平均重量(mg) ・硬度(N) シュロイニゲル硬度計(フロイント産業製)を用いて測
定する。10個の平均で表す。 ・崩壊時間(秒) 日本薬局方13改正の崩壊時間測定法に従い、蒸留水を
使用して測定する。6個の平均で表す。
CV value (%) = 100 × standard deviation (mg)
/ Average weight (mg) Hardness (N) Measured using a Schleunigel hardness tester (manufactured by Freund Corporation). Expressed as an average of ten. -Disintegration time (sec) Measure using distilled water in accordance with the disintegration time measurement method of the Japanese Pharmacopoeia 13 revision. Expressed as an average of six.

【0020】なお、本発明で使用したセルロース試料の
物性について、表1に示す。
Table 1 shows the physical properties of the cellulose samples used in the present invention.

【0021】[0021]

【実施例1】セルロースA240g(粉体中で15
%)、200メッシュ乳糖(DMV社製)1040g、
フェナセチン(山本化学工業製)160g、トウモロコ
シデンプン(日澱化学製)160gをニュースピードニ
ーダー(パウテックス社製、SK250型)に仕込み、
1分間500rpmで撹拌し、混合する。次に、同条件
で撹拌しながら、6%ヒドロキシプロピルセルロース
(低粘度型:日本曹達社製)水溶液400gを約30秒
間で添加し、さらに5分間撹拌した。得られた湿顆粒を
40℃で1夜乾燥し、顆粒を得た。顆粒を1410μm
で篩過した後、顆粒の物性を測定した。結果を表2に示
す。
Example 1 240 g of cellulose A (15 g in powder)
%), 1040 g of 200 mesh lactose (manufactured by DMV),
160 g of phenacetin (manufactured by Yamamoto Chemical Co., Ltd.) and 160 g of corn starch (manufactured by Nichien Chemical Co., Ltd.) were charged into a new speed kneader (model SK250, manufactured by Powtex),
Stir at 500 rpm for 1 minute and mix. Next, while stirring under the same conditions, 400 g of a 6% aqueous solution of hydroxypropylcellulose (low viscosity type: manufactured by Nippon Soda Co., Ltd.) was added in about 30 seconds, and the mixture was further stirred for 5 minutes. The obtained wet granules were dried at 40 ° C. overnight to obtain granules. Granules 1410 μm
After sieving, the physical properties of the granules were measured. Table 2 shows the results.

【0022】続いて、顆粒800g、ステアリン酸マグ
ネシウム4gをポリエチレン袋中で30秒間ゆっくり混
合した後、ロータリー打錠機(菊水製作所製、コレクト
12HUK)を用いて、8mm径、12Rの大きさの2
00mg錠を打錠圧100Mpaで成形した。得られた
錠剤の物性について表2に示す。
Subsequently, 800 g of the granules and 4 g of magnesium stearate were gently mixed in a polyethylene bag for 30 seconds, and then, using a rotary tableting machine (manufactured by Kikusui Seisakusho, Collect 12HUK), 2 g of 8 mm in diameter and 12R in size were used.
A 00 mg tablet was formed at a compression pressure of 100 MPa. Table 2 shows the physical properties of the obtained tablets.

【0023】[0023]

【実施例2】造粒時の6%ヒドロキシプロピルセルロー
ス水溶液の添加量を290gとする以外は実施例1と同
様に操作した。顆粒、錠剤物性の結果を表2に示す。
Example 2 The same operation as in Example 1 was carried out except that the amount of the 6% aqueous solution of hydroxypropylcellulose added during granulation was 290 g. Table 2 shows the results of the physical properties of the granules and tablets.

【0024】[0024]

【実施例3】造粒時の6%ヒドロキシプロピルセルロー
ス水溶液の添加量を460gとする以外は実施例1と同
様に操作した。顆粒、錠剤物性の結果を表2に示す。
Example 3 The same operation as in Example 1 was carried out except that the amount of the 6% aqueous solution of hydroxypropylcellulose added during granulation was 460 g. Table 2 shows the results of the physical properties of the granules and tablets.

【0025】[0025]

【実施例4】セルロースAの代わりにセルロースBを用
い、6%ヒドロキシプロピルセルロース水溶液の添加量
を320gとする以外は、実施例1と同様に操作した。
顆粒、錠剤物性の結果を表2に示す。
Example 4 The procedure of Example 1 was repeated, except that cellulose B was used instead of cellulose A, and the amount of the 6% aqueous solution of hydroxypropylcellulose was changed to 320 g.
Table 2 shows the results of the physical properties of the granules and tablets.

【0026】[0026]

【実施例5】セルロースAの代わりにセルロースBを用
い6%ヒドロキシプロピルセルロース水溶液の添加量を
380gとするる以外は、実施例1と同様に実施した。
顆粒、錠剤物性の結果を表2に示す。
Example 5 The same procedure as in Example 1 was carried out except that cellulose B was used instead of cellulose A and the amount of the 6% aqueous solution of hydroxypropylcellulose was changed to 380 g.
Table 2 shows the results of the physical properties of the granules and tablets.

【0027】[0027]

【実施例6】セルロースA80g(粉体中で5%)、2
00メッシュ乳糖(DMV社製)1160g、フェナセ
チン(山本化学工業製)200g、トウモロコシデンプ
ン(日澱化学製)160gを粉体として使用し、6%ヒ
ドロキシプロピルセルロース水溶液の添加量を240g
とするる以外は、実施例1と同様に実施した。顆粒、錠
剤物性の結果を表2に示す。
Example 6 80 g of cellulose A (5% in powder), 2
Using 1160 g of 00 mesh lactose (manufactured by DMV), 200 g of phenacetin (manufactured by Yamamoto Kagaku Kogyo), and 160 g of corn starch (manufactured by Nisseki Chemical) as powders, the addition amount of a 6% hydroxypropylcellulose aqueous solution was 240 g.
Except for that, the procedure was performed in the same manner as in Example 1. Table 2 shows the results of the physical properties of the granules and tablets.

【0028】[0028]

【実施例7】セルロースA400g(粉体中で25
%)、200メッシュ乳糖(DMV社製)880g、フ
ェナセチン(山本化学工業製)200g、トウモロコシ
デンプン(日澱化学製)120gを粉体として使用し、
6%ヒドロキシプロピルセルロース水溶液の添加量を4
40gとするる以外は、実施例1と同様に実施した。顆
粒、錠剤物性の結果を表2に示す。
Example 7 400 g of cellulose A (25 in powder)
%), 880 g of 200 mesh lactose (manufactured by DMV), 200 g of phenacetin (manufactured by Yamamoto Kagaku Kogyo), and 120 g of corn starch (manufactured by Nisseki Chemical) as powders,
The amount of 6% hydroxypropylcellulose aqueous solution added was 4
It carried out similarly to Example 1 except having set it to 40 g. Table 2 shows the results of the physical properties of the granules and tablets.

【0029】[0029]

【実施例8】セルロースA240g(粉体中で15
%)、200メッシュ乳糖(DMV社製)400g、ア
スコルビン酸(保栄薬工製)800g、トウモロコシデ
ンプン(日澱化学製)160gをニュースピードニーダ
ー(パウテックス社製、SK250型)に仕込み、1分
間500rpmで撹拌し、混合する。次に、同条件で撹
拌しながら、6%ヒドロキシプロピルセルロース(低粘
度型:日本曹達社製)水溶液350gを約30秒間で添
加し、さらに5分間撹拌した。得られた湿顆粒を40℃
で1夜乾燥し、顆粒を得た。顆粒を1410μmで篩過
した後、顆粒の物性を測定した。結果を表2に示す。
Example 8 240 g of cellulose A (15 g in powder)
%), 400 g of 200 mesh lactose (manufactured by DMV), 800 g of ascorbic acid (manufactured by Hoei Pharmaceutical Co., Ltd.), and 160 g of corn starch (manufactured by Nisseki Chemical) are charged in a new speed kneader (model SK250, manufactured by Powtex) at 500 rpm for 1 minute. Stir and mix. Next, while stirring under the same conditions, 350 g of a 6% aqueous solution of hydroxypropylcellulose (low-viscosity type: manufactured by Nippon Soda Co., Ltd.) was added in about 30 seconds, and the mixture was further stirred for 5 minutes. The obtained wet granules are heated at 40 ° C.
And dried overnight to obtain granules. After sieving the granules at 1410 μm, the physical properties of the granules were measured. Table 2 shows the results.

【0030】続いて、顆粒800g、ステアリン酸マグ
ネシウム4gをポリエチレン袋中で30秒間ゆっくり混
合した後、ロータリー打錠機(菊水製作所製、コレクト
12HUK)を用いて、8mm径、12Rの大きさの2
00mg錠を打錠圧100Mpaで成形した。得られた
錠剤の物性について表2に示す。
Subsequently, 800 g of the granules and 4 g of magnesium stearate were gently mixed in a polyethylene bag for 30 seconds, and then, using a rotary tableting machine (manufactured by Kikusui Seisakusho, Collect 12HUK), 2 g of 8 mm in diameter and 12R in size were used.
A 00 mg tablet was formed at a compression pressure of 100 MPa. Table 2 shows the physical properties of the obtained tablets.

【0031】[0031]

【実施例9】セルロースAの代わりにセルロースBを用
い、6%ヒドロキシプロピルセルロース水溶液の添加量
を180gとする以外は、実施例8と同様に操作した。
但し、湿顆粒の乾燥は湿顆粒1.3kgを流動層アタッ
チメントを装着したマルチプレックスMP−01に仕込
んで、入口温度75℃、風量500L/分で流動させ、
排風温度が50℃になるまで乾燥した。また、顆粒80
0g、セルロースA100gをポリ袋で2分間混合して
から、ステアリン酸マグネシウム4gを混合した後、打
錠を行った。顆粒、錠剤物性の結果を表2に示す。
Example 9 The procedure of Example 8 was repeated, except that cellulose B was used instead of cellulose A, and the amount of the 6% aqueous solution of hydroxypropylcellulose was changed to 180 g.
However, for drying the wet granules, 1.3 kg of the wet granules were charged into a multiplex MP-01 equipped with a fluidized bed attachment, and were allowed to flow at an inlet temperature of 75 ° C. and an air flow of 500 L / min.
It dried until exhaust temperature reached 50 degreeC. Also, granules 80
After mixing 0 g and 100 g of cellulose A in a plastic bag for 2 minutes, 4 g of magnesium stearate was mixed, followed by tableting. Table 2 shows the results of the physical properties of the granules and tablets.

【0032】[0032]

【比較例1】セルロース粉末無添加で、6%ヒドロキシ
プロピルセルロース水溶液を200g添加する以外は実
施例1と同様に操作した。顆粒、錠剤物性の結果を表3
に示す。
Comparative Example 1 The same operation as in Example 1 was carried out except that 200 g of a 6% aqueous solution of hydroxypropylcellulose was added without adding cellulose powder. Table 3 shows the results of physical properties of granules and tablets.
Shown in

【0033】[0033]

【比較例2】造粒時の6%ヒドロキシプロピルセルロー
ス水溶液の添加量を200gとする以外は実施例1と同
様に操作した。顆粒、錠剤物性の結果を表3に示す。
Comparative Example 2 The same operation as in Example 1 was carried out except that the amount of the 6% aqueous solution of hydroxypropylcellulose used during granulation was changed to 200 g. Table 3 shows the results of the physical properties of the granules and tablets.

【0034】[0034]

【比較例3】造粒時の6%ヒドロキシプロピルセルロー
ス水溶液の添加量を550gとする以外は実施例1と同
様に操作した。顆粒、錠剤物性の結果を表3に示す。
Comparative Example 3 The same operation as in Example 1 was performed except that the amount of the 6% aqueous hydroxypropylcellulose solution added during granulation was changed to 550 g. Table 3 shows the results of the physical properties of the granules and tablets.

【0035】[0035]

【比較例4】造粒時間を10分間とする以外は、実施例
5と同様に操作した。顆粒、錠剤物性の結果を表3に示
す。
Comparative Example 4 The operation was performed in the same manner as in Example 5, except that the granulation time was changed to 10 minutes. Table 3 shows the results of the physical properties of the granules and tablets.

【0036】[0036]

【比較例5】セルロースA560g(粉体中で35
%)、200メッシュ乳糖(DMV社製)740g、フ
ェナセチン(山本化学工業製)200g、トウモロコシ
デンプン(日澱化学製)100gを粉体として使用し、
6%ヒドロキシプロピルセルロース水溶液の添加量を5
20gとする以外は、実施例1と同様に実施した。顆
粒、錠剤物性の結果を表3に示す。
Comparative Example 5 560 g of cellulose A (35 in powder)
%), 740 g of 200 mesh lactose (manufactured by DMV), 200 g of phenacetin (manufactured by Yamamoto Kagaku Kogyo), and 100 g of corn starch (manufactured by Nisseki Chemical) as powders.
The amount of 6% hydroxypropylcellulose aqueous solution
It carried out similarly to Example 1 except having set it to 20 g. Table 3 shows the results of the physical properties of the granules and tablets.

【0037】[0037]

【表1】 [Table 1]

【0038】[0038]

【表2】 [Table 2]

【0039】[0039]

【表3】 [Table 3]

【0040】[0040]

【発明の効果】セルロース粉末を2〜30重量%含有す
る粉体を造粒して特定の物性を持つ顆粒とし、その顆粒
を打錠する本発明の錠剤の製造方法によると、顆粒の流
動性が良好であるため、錠剤の重量バラツキが小さく、
また、錠剤硬度が高いにも関わらず、崩壊時間が速いと
いう実用的な錠剤を製造することができる。
According to the tablet manufacturing method of the present invention in which a powder containing 2 to 30% by weight of a cellulose powder is granulated into granules having specific physical properties and the granules are compressed, the flowability of the granules is improved. Is good, the weight variation of the tablet is small,
In addition, a practical tablet having a fast disintegration time despite high tablet hardness can be produced.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 セルロース粉末を2〜30重量%含有す
る粉体を湿式造粒し顆粒を製した後、打錠する湿式打錠
法により錠剤を製造する方法であって、顆粒が、平均粒
径60〜300μm、粒径均一度3.0以下、粗比容積
1.5〜2.5ml/g、安息角35〜42度であるこ
とを特徴とする、錠剤の製造方法。
1. A method for producing tablets by wet granulation, comprising granulating granules by wet granulation of a powder containing 2 to 30% by weight of cellulose powder, and then compressing the granules. A method for producing a tablet, characterized by having a diameter of 60 to 300 µm, a particle size uniformity of 3.0 or less, a coarse specific volume of 1.5 to 2.5 ml / g, and a repose angle of 35 to 42 degrees.
JP2000174710A 2000-06-12 2000-06-12 Method for preparing tablet Pending JP2001347153A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000174710A JP2001347153A (en) 2000-06-12 2000-06-12 Method for preparing tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000174710A JP2001347153A (en) 2000-06-12 2000-06-12 Method for preparing tablet

Publications (1)

Publication Number Publication Date
JP2001347153A true JP2001347153A (en) 2001-12-18

Family

ID=18676696

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000174710A Pending JP2001347153A (en) 2000-06-12 2000-06-12 Method for preparing tablet

Country Status (1)

Country Link
JP (1) JP2001347153A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006521300A (en) * 2003-03-31 2006-09-21 プリヴァ−ラケマ,エー.エス. Pharmaceutical composition containing platinum complex as active substance and method for producing the same
JPWO2009101940A1 (en) * 2008-02-11 2011-06-09 大日本住友製薬株式会社 Tablets with improved dissolution
US8106100B2 (en) 2005-12-06 2012-01-31 Asahi Kasei Chemicals Corporation Process for producing tablet by high-speed direct compression
JP2017061577A (en) * 2012-05-31 2017-03-30 旭化成株式会社 Cellulose powder

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006521300A (en) * 2003-03-31 2006-09-21 プリヴァ−ラケマ,エー.エス. Pharmaceutical composition containing platinum complex as active substance and method for producing the same
US8106100B2 (en) 2005-12-06 2012-01-31 Asahi Kasei Chemicals Corporation Process for producing tablet by high-speed direct compression
JPWO2009101940A1 (en) * 2008-02-11 2011-06-09 大日本住友製薬株式会社 Tablets with improved dissolution
JP5401327B2 (en) * 2008-02-11 2014-01-29 大日本住友製薬株式会社 Tablets with improved dissolution
JP2017061577A (en) * 2012-05-31 2017-03-30 旭化成株式会社 Cellulose powder
JP2018016818A (en) * 2012-05-31 2018-02-01 旭化成株式会社 Cellulose powder
JP2019049012A (en) * 2012-05-31 2019-03-28 旭化成株式会社 Cellulose powder

Similar Documents

Publication Publication Date Title
AU2001267860B2 (en) Cellulose powder
CA2734847C (en) Novel excipient for mannitol tableting
AU2008264445B2 (en) Pharmaceutical solid preparation comprising benzazepines and production method thereof
JPWO2003082279A1 (en) Solid formulation containing a single crystal form
EP0910344A1 (en) Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
JP2008531737A (en) Wet granulation pharmaceutical composition of aripiprazole
JP2994956B2 (en) Low-substituted hydroxypropylcellulose, composition thereof and tablet thereof
CN109789141B (en) Pharmaceutical compositions comprising Akt protein kinase inhibitors
JPH11322802A (en) Hydroxypropylcellulose having low substitution degree and its production
CA2737380C (en) Tabletting excipient based on lactose and cellulose
JPH10279601A (en) Low-substitution-degree hydroxypropylcellulose powder
JP3595765B2 (en) Base for dry direct hitting containing low substituted hydroxypropylcellulose
CN111920778A (en) Levetiracetam tablet and preparation method thereof
JPH0538732B2 (en)
WO2023108895A1 (en) Telmisartan oral solid preparation with stable product performance, and preparation method therefor
JP4925526B2 (en) Drug mixing method
JP2001114703A (en) Solid medicine and method for producing the same
JP2001347153A (en) Method for preparing tablet
JP4698000B2 (en) Easily water-soluble drug-containing tablets
KR20210038414A (en) Solid preparations of pharmaceuticals containing stabilizers
JP2000034224A (en) Sustained-release tablet, additive composition for the tablet, and their production
JP4774739B2 (en) Kampo extract-containing tablet composition and method for producing the same
US7009046B2 (en) Low-substituted hydroxypropyl cellulose and agent serving both as binder and disintegrant for dry direct compression
JP6892245B2 (en) Ilbesartan-containing pharmaceutical composition
KR101817714B1 (en) Oral solid composite comprising valsartan

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070524

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20091022

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091027

A521 Written amendment

Effective date: 20091222

Free format text: JAPANESE INTERMEDIATE CODE: A523

A02 Decision of refusal

Effective date: 20100302

Free format text: JAPANESE INTERMEDIATE CODE: A02